An optimal medical therapy for efficient cardiovascular protection in subjects with coronary artery diseases in Japan: Comparisons and analyses by quasi-randomized controlled trials with propensity score matching and inverse probability treatment weighting methods for a Japanese cohort-Reference-Cited by-同舟云学术

An optimal medical therapy for efficient cardiovascular protection in subjects with coronary artery diseases in Japan: Comparisons and analyses by quasi-randomized controlled trials with propensity score matching and inverse probability treatment weighting methods for a Japanese cohort

Published:2020-12-21 Issue:1 Volume:4 Page:7-15
ISSN:2432-4477
Container-title:Vascular Failure
language:en
Short-container-title:Vasc Fail

Author:

Kino Tabito¹,Ishigami Tomoaki¹,Doi Hiroshi¹,Chen Lin¹,Nakashima-Sasaki Rie¹,Sugiyama Michiko¹,Arakawa Kentaro¹,Minegishi Shintaro¹,Abe Kaito¹,Wakui Hiromichi¹,Azushima Kengo¹,Tamura Kouichi¹

Affiliation:

1. Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine

Publisher

Japan Society for Vascular Failure

Link

https://www.jstage.jst.go.jp/article/vascfail/4/1/4_7/_pdf

Reference36 articles.

1. 1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006; 6: 508-19.

2. 2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.

3. 3. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. The New England Journal of Medicine 2007; 356: 1503-16.

4. 4. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, et al. Effect of PCI on quality of life in patients with stable coronary disease. The New England Journal of Medicine 2008; 359: 677-87.

5. 5. Smith SC, Jr., Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-72.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction in Arterial Stiffness after Switching from Pravastatin or Atorvastatin to Fluvastatin;Vascular Failure;2021-12-25